Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Nausea cannabidiol:

Search results

Items: 1 to 20 of 71

1.

Increased Use of Medical Marijuana: Skepticism vs. Evidence.

Wick JY.

Consult Pharm. 2018 Dec 1;33(12):680-689. doi: 10.4140/TCP.n.2018.680..

PMID:
30545431
2.

Impact of recreational and medicinal marijuana on surgical patients: A review.

Bakshi C, Barrett AM.

Am J Surg. 2018 Nov 14. pii: S0002-9610(18)31123-1. doi: 10.1016/j.amjsurg.2018.10.053. [Epub ahead of print] Review.

PMID:
30471810
3.

Cannabis for the treatment of Crohn's disease.

Kafil TS, Nguyen TM, MacDonald JK, Chande N.

Cochrane Database Syst Rev. 2018 Nov 8;11:CD012853. doi: 10.1002/14651858.CD012853.pub2. Review.

PMID:
30407616
4.

Cannabis for the treatment of ulcerative colitis.

Kafil TS, Nguyen TM, MacDonald JK, Chande N.

Cochrane Database Syst Rev. 2018 Nov 8;11:CD012954. doi: 10.1002/14651858.CD012954.pub2. Review.

PMID:
30406638
5.

Medical Use of Cannabinoids.

Fraguas-Sánchez AI, Torres-Suárez AI.

Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Review.

PMID:
30374797
7.

Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids.

Jacobs NI, Montebello M, Monds LA, Lintzeris N.

Australas Psychiatry. 2018 Oct 9:1039856218803675. doi: 10.1177/1039856218803675. [Epub ahead of print]

PMID:
30298754
8.

Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol.

Kenyon J, Liu W, Dalgleish A.

Anticancer Res. 2018 Oct;38(10):5831-5835. doi: 10.21873/anticanres.12924.

PMID:
30275207
9.

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Mersiades AJ, Tognela A, Haber PS, Stockler M, Lintzeris N, Simes J, McGregor I, Olver I, Allsop DJ, Gedye C, Kirby AC, Morton RL, Fox P, Clarke S, Briscoe K, Aghmesheh M, Wong N, Walsh A, Hahn C, Grimison P.

BMJ Open. 2018 Sep 12;8(9):e020745. doi: 10.1136/bmjopen-2017-020745.

10.

A Brief Background on Cannabis: From Plant to Medical Indications.

Klumpers LE, Thacker DL.

J AOAC Int. 2018 Aug 23. doi: 10.5740/jaoacint.18-0208. [Epub ahead of print]

PMID:
30139415
11.

Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience.

Chen KA, Farrar M, Cardamone M, Gill D, Smith R, Cowell CT, Truong L, Lawson JA.

Med J Aust. 2018 Aug 3;209(5):217-221. Epub 2018 Aug 13.

PMID:
30092753
12.

Nausea-Induced 5-HT Release in the Interoceptive Insular Cortex and Regulation by Monoacylglycerol Lipase (MAGL) Inhibition and Cannabidiol.

Limebeer CL, Rock EM, Sharkey KA, Parker LA.

eNeuro. 2018 Jul 31;5(4). pii: ENEURO.0256-18.2018. doi: 10.1523/ENEURO.0256-18.2018. eCollection 2018 Jul-Aug.

13.

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases.

Darkovska-Serafimovska M, Serafimovska T, Arsova-Sarafinovska Z, Stefanoski S, Keskovski Z, Balkanov T.

J Pain Res. 2018 Apr 23;11:837-842. doi: 10.2147/JPR.S160556. eCollection 2018. Review.

14.

Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay.

Cuñetti L, Manzo L, Peyraube R, Arnaiz J, Curi L, Orihuela S.

Transplant Proc. 2018 Mar;50(2):461-464. doi: 10.1016/j.transproceed.2017.12.042.

PMID:
29579828
15.

Cannabis Use, Lung Cancer, and Related Issues.

Jett J, Stone E, Warren G, Cummings KM.

J Thorac Oncol. 2018 Apr;13(4):480-487. doi: 10.1016/j.jtho.2017.12.013. Epub 2018 Jan 31. Review.

PMID:
29374567
16.
17.

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation.

Zgair A, Lee JB, Wong JCM, Taha DA, Aram J, Di Virgilio D, McArthur JW, Cheng YK, Hennig IM, Barrett DA, Fischer PM, Constantinescu CS, Gershkovich P.

Sci Rep. 2017 Nov 6;7(1):14542. doi: 10.1038/s41598-017-15026-z.

18.

A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity.

Marinelli L, Balestrino M, Mori L, Puce L, Rosa GM, Giorello L, Currà A, Fattapposta F, Serrati C, Gandolfo C, Abbruzzese G, Trompetto C.

BMJ Open. 2017 Sep 7;7(9):e016843. doi: 10.1136/bmjopen-2017-016843.

19.

A selective review of medical cannabis in cancer pain management.

Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O'Hearn S.

Ann Palliat Med. 2017 Dec;6(Suppl 2):S215-S222. doi: 10.21037/apm.2017.08.05. Epub 2017 Aug 23. Review.

20.

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans.

Nahler G, Grotenhermen F, Zuardi AW, Crippa JAS.

Cannabis Cannabinoid Res. 2017 May 1;2(1):81-86. doi: 10.1089/can.2017.0009. eCollection 2017.

Supplemental Content

Loading ...
Support Center